Autoimmune Encephalitis:

Building Bridges

Online Symposium

April 10, 2021

Presented by

AE Alliance and Hashimoto’s Encephalopathy SREAT Alliance (HESA)

The goal of this conference was to enhance patient care and improve outcomes for those affected by autoimmune encephalitis, by promoting a multidisciplinary approach to diagnosis, treatment, and recovery. ‘Building Bridges’, is a place to exchange ideas, collaborate and learn from each other by starting a dialogue across the disciplines of immunology, neurology, psychiatry, and rheumatology. The symposium was designed for health care professionals and medical students. 

Go to the 'Symposium Recordings' page to view all presentations.

Thank you to Quest Diagnostics for sponsoring this event. 

bb-schedule graphic.jpg

What Are Autoimmune Encephalitides?

The autoimmune encephalitides are a group of autoimmune conditions targeting the central nervous system and causing severe clinical symptoms including drug-resistant seizures, cognitive dysfunction and psychiatric disturbance. Autoimmune encephalitis is seen in a broad age range but most commonly affects young people. The annual incidence of encephalitis is up to 12.6 per 100,000 individuals, 20–30% of whom have

an underlying autoimmune etiology.


Over the last years the clinical picture of autoimmune encephalitis has gained importance in neurology. The broad field of symptoms and syndromes poses a great challenge in diagnosis for clinicians. Early diagnosis and the initiation of the appropriate treatment is the most relevant step in the management of these patients. 


However, the clinical spectrum is broad, including psychosis, catatonia, alterations of behavior and memory, seizures, abnormal movements, and autonomic dysregulation and it is important to look beyond the borders of neurology and to integrate other medical disciplines in the concepts of disease management.



by Morgan Boehme